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Plectin belongs to the plakin family of 
cytoskeletal crosslinkers, which is part of the 
spectrin superfamily. Plakins contain an N-
terminal conserved region, the plakin domain, 
which is formed by an array of spectrin repeats 
(SR) and a Src-homology 3 (SH3), and harbors 
binding sites for junctional proteins. We have 
combined X-ray crystallography and small 
angle X-ray scattering (SAXS) to elucidate the 
structure of the central region of the plakin 
domain of plectin, which corresponds to the 
SR3, SR4, SR5, and SH3 domains. The crystal 
structures of the SR3-SR4 and SR4-SR5-SH3 
fragments were determined to 2.2 and 2.95 Å 
resolution, respectively. The SH3 of plectin 
presents major alterations as compared with 
canonical Pro-rich binding SH3 domains, 
suggesting that plectin does not recognize Pro-
rich motifs. In addition, the SH3 binding site is 
partially occluded by an intramolecular contact 
with the SR4. Residues of this pseudo-binding 
site and the SR4/SH3 interface are conserved 
within the plakin family, suggesting that the 
structure of this part of the plectin molecule is 
similar to that of other plakins. We have 
created a model for the SR3-SR4-SR5-SH3 
region, which agrees well with SAXS data in 
solution. The three SR form a semi-flexible rod 
that is not altered by the presence of the SH3 
domain, and it is similar to those found in 
spectrins. The flexibility of the plakin domain, 
in analogy with spectrins, might contribute to 
the role of plakins in maintaining the stability 
of tissues subject to mechanical stress. 
 
Plakins are a family of high molecular 
weight proteins that interconnect elements of the 
cytoskeleton and tether them to membrane 
associated structures; hence, they are also known 
as cytolinkers (1-2). Mammalian plakins include 
desmoplakin, plectin, the bullous pemphigoid 
antigen 1 (BPAG1), the microtubule actin cross-
linking factor 1 (MACF1, also known as ACF7, 
trabeculin, or macrophin), envoplakin, periplakin, 
and epiplakin. Plakins are also present in 
invertebrates; Drosophila melanogaster has a 
single plakin gene named shortstop (also know as 
kakapo) that encodes at least two protein forms, 
Shot I and Shot II. Similarly, the only plakin gene 
in Caenorhabditis elegans, vab-10, encodes two 
variants VAB-10A and VAB-10B. 
Plectin is a highly versatile plakin that 
associates with intermediate filaments (3), 
microtubules (4), and actin fibers (5), and 
crosslinks these cytoskeletal networks (5-6). 
Plectin also connects intermediate filaments to 
membrane associated complexes. In stratified 
epithelia such as the skin, plectin is localized at the 
hemidesmosomes, which are junctional complexes 
that link the intermediate filaments to the 
basement membrane, and links the integrin 64 
and the bullous pemphigoid antigen 2 (BPAG2, 
also known as type XVII collagen or BP180) to 
the cytokeratins (7-8). Plectin is also localized at 
the desmosomes (9), which mediate cell-cell 
contacts, and connects the nuclear envelope to the 
intermediate filaments by binding to the outer 
nuclear membrane protein nesprin-3 (10-11). In 
striated muscle, plectin is localized at the Z-line 
and the costameres, where it associates with the 
intermediate filament protein desmin and with 
components of the dystrophin glycoprotein 
complex (12-15). The contribution of plectin to 
preserve the integrity of tissues that are exposed to 
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mechanical stress is illustrated by the effect of 
mutations in the PLEC gene, which lead to a 
severe skin blistering disease called epidermolysis 
bullosa simplex that is characterized by defects at 
the level of the hemidesmosomal cell-basal 
membrane junction and is frequently associated 
with late-onset muscular dystrophy (16-17).  
Plectin (~500 kDa) has a tripartite structure 
consisting of N- and C-terminal regions separated 
by a central rod domain (Fig 1A). Other epithelial 
plakins such as BPAG1e/n, desmoplakin, 
periplakin, and envoplakin have the same 
structure. Near the N-terminus plectin contains an 
actin binding domain (ABD) build up of a tandem 
pair of calponin homology domains (CH1 and 
CH2), similar to the ABDs present in dystrophin 
and other members of the spectrin superfamily. 
The ABD binds to the first pair of fibronectin type 
III repeats of the integrin 4 subunit via the CH1 
domain (18-20); the ABD also binds to F-actin 
(21-22), nesprin-3 (11), and to nonfilamentous 
vimentin (23). Adjacent to the ABD extends a 
~1000 residue long region named the plakin 
domain that is conserved in all plakins, except in  
epiplakin. The plakin domain of plectin and other 
plakins contain protein-protein interaction sites 
and they are important for the localization of 
plakins at junctional complexes. In plectin this 
region harbors binding sites for the integrin 4 
subunit (24), the cytoplasmic domain of BPAG2 
(25), -dystroglycan (13), -synemin (15), and the 
tyrosine kinase Fer (26). The central region 
consists of a coiled-coil rod domain that acts as a 
structural spacer of the protein-protein binding 
sites located in the N- and C-terminal regions and 
mediates homo-dimerization of plectin. Finally, 
the C-terminal region contains six plakin repeat 
domains and harbors binding sites for intermediate 
filaments.  
Initial analysis of the sequence of the plakin 
domain suggested that this region contains 
multiple -helical bundles (27), some of which 
were later identified as spectrin repeats (SR) (28). 
The presence of SRs in the plakin domain was 
confirmed by the crystal structures of two di-
repeat fragments of BPAG1 (29) and plectin (30). 
The SR-fold (~100-residues long) consists of three 
-helices connected by short loops that pack in a 
left-handed helical bundle with up-down-up 
topology (31-32). The -helices show a heptad 
pattern in which positions a and d are occupied by 
hydrophobic residues that pack at the core of the 
bundle. Adjacent SRs in the structures of BPAG1, 
plectin, and those of other pairs of SRs are 
connected by a helical linker in which the third -
helix (C) of the N-terminal repeat and the first -
helix (A) of the C-terminal SR are fused into a 
single helix. Thus, arrays of multiple SRs form 
rod-like structures, as it was illustrated by the 
crystal structure of a tetra-repeat rod of -actinin 
(33). We have previously identified eight 
canonical SRs in the sequence of the plakin 
domain of plectin (SR1 to SR5 and SR7 to SR9), 
and an additional shorter SR-like domain (SR6) 
(Fig 1A) (30). The available crystal structures of 
plectin and BPAG1 correspond to the SR1-SR2 
and SR3-SR4, respectively. The SR2 and SR3 of 
plectin are connected by a ~20-residues long linker 
predicted to be non-helical, while repeats SR3 to 
SR9 occur contiguous in the plectin sequence as 
observed in the structure of the SR3-SR4 pair of 
BPAG1 (29). In addition to the SRs, there is a Src-
homology 3 (SH3) domain toward the middle of 
the plakin domain (29); this is of interest because 
SH3 domains mediate protein-protein interactions, 
frequently binding to Pro-rich sequences (34). The 
SH3 domain is inserted in the central repeat, SR5, 
and this arrangement is almost identical to that of 
-spectrin in which there is an SH3 within the 
central SR; for which the relative organization of 
the SH3 and the SRs is unknown. Overall, the 
structural organization of the plakin domain is 
highly similar to that of - and -spectrins and 
other members of the spectrin superfamily, both 
regarding the repertoire of modules (ABD, SR, 
and SH3) and their arrangement. 
In spite of recent advances in the 
characterization of the structure and function of 
the plakin domain, important issues remained 
unanswered. Does the plakin domain adopt a rod-
like structure formed by juxtaposed SRs similar to 
that of spectrins and related proteins? If so, does 
the insertion of the SH3 domain alter the SR-
array? Is the structure of the SH3 domain 
compatible with ligand binding and is its binding 
site accessible? In order to address these questions, 
we have combined X-ray crystallography and 
small angle X-ray scattering (SAXS) to elucidate 
the structure of the central region of the plakin 
domain of plectin, which includes the SR3, SR4, 
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SR5 and the SH3; a region that is involved in 
protein-protein interactions. Our results have 
implications for the contribution of the plakin 
domain of plectin and other plakins to the stability 
of junctional complexes subject to mechanical 
forces.  
 
EXPERIMENTAL PROCEDURES 
Protein expression and purification- The cDNA 
sequences coding for residues 543-748, 640-918, 
and 543-918 of human plectin (numbering 
correspond to the plectin 1c variant, UniprotKB 
accession number Q15149-2) were cloned into a 
modified version of the pET15b vector (35). 
Proteins were expressed in Escherichia coli strain 
BL21(DE3) and were purified by nickel-chelating 
affinity chromatography as described (22). The 
His-tag present at the N-terminus of the fusion 
proteins was cleaved by digestion with tobacco 
etch virus protease, and was removed by a second 
nickel-affinity chromatography. 
 
Crystallization and structure determination of the 
SR3-SR4 region- Crystals of SR3-SR4 (residues 
543-748) were grown at 4ºC using vapor diffusion 
methods by mixing a protein solution at 31 mg/ml 
in 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 0.1 
mM DTT with an equal volume of mother liquor 
consisting of 0.1 M HEPES (pH 7.5), 17% (w/v) 
polyethylene glycol (PEG) 4000, and 8% (v/v) 
isopropanol. Prior to data collection, crystals were 
transferred into a cryoprotectant solution 
consisting of 0.1 M HEPES (pH 7.5), 18% (w/v) 
PEG 4000, and 6% (v/v) isopropanol, and 20% 
(v/v) glycerol that was vitrified by direct 
immersion in liquid nitrogen. Data were collected 
at 100 K using a Microstar-H rotating anode X-ray 
generator (Bruker AXS) and a mar345dtb detector 
(Marresearch GmbH). Diffraction intensities were 
indexed and integrated with XDS and reduced 
with XSCALE (36).  
Crystals belong to space group P21212 and contain 
two molecules in the asymmetric unit (~54% 
solvent content) (Table 1). A mixed search model 
for molecular replacement (37) was built by 
homology modeling using as template the crystal 
structure of the equivalent region of BPAG1 (PDB 
code 2IAK)(29) that corresponds to ~85% of the 
residues of the plectin fragment and have ~65% 
sequence identity. Our data were then phased by 
molecular replacement using the program 
PHASER (38) within the CCP4 suite (39). 
Refinement was done against data to 2.22 Å 
resolution using phenix.refine (40), alternated with 
manual model building using COOT (41). This 
partial structure was completed based on 
additional electron density observed in the 2mFo-
DFc maps. Simulated annealing was used in the 
initial stages of refinement, while gradient-driven 
positional refinement, individual isotropic B-factor 
restrained refinement and TLS refinement (42) 
were used at later stages. Three TLS groups 
identified by using the TLS Motion Determination 
server (43) were refined in each molecule. Non-
crystallographic symmetry restraints were not 
included during refinement. Solvent molecules 
were built in peaks over 3 of mfobs-Dfcalc maps 
and 1 of 2mfobs-Dfcalc maps when reasonable H-
bonding pattern was observed. Two elongated 
electron densities not belonging to the protein 
chains were modeled as two PEG fragments, 
ethylene glycol and di(hydroxyethyl)ether, 
respectively. The final model contains residues 
545-746 of molecule A, residues 543-745 of the 
molecule B, 210 water molecules and two PEG 
fragments. The model has excellent geometry with 
99.5% of the main-chain torsion angles located in 
the favored regions of the Ramachandran plot. 
 
Crystallization and structure determination of the 
SR4-SR5-SH3 region- Crystals of the SR4-SR5-
SH3 protein (residues 640-918) were grown at 4ºC 
using vapor diffusion methods by mixing a protein 
solution at 15 mg/ml in 10 mM Tris-HCl (pH 7.5), 
50 mM NaCl, 1 mM DTT with an equal volume of 
mother liquor consisting of 0.1 M imidazole (pH 
7.2), 0.2 M Ca acetate, 9% (w/v) PEG 8000, and 2 
mM DTT. After crystals were grown, the drop 
containing the crystals was equilibrated for ~36 
hours against a solution with twice the 
concentration of all the components in the initial 
crystallization solution. Before data collection, the 
crystal was transferred to 0.2 M imidazole (pH 
7.2), 0.4 M Ca acetate, 18% (w/v) PEG 8000, 4 
mM DTT, and increasing concentrations of 
glycerol up to 20%.  
Crystals for heavy-atom derivatization were grown 
as for native crystals, but using 0.1 M imidazole 
(pH 7.6), 0.2 M Ca acetate, 10% (w/v) PEG 8000, 
and 2 mM DTT as crystallization solution. 
Crystals were soaked for 3.5 hours in 0.1 M 
imidazole (pH 7.6), 0.2 M Ca acetate, 12% (w/v) 
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PEG 8000, 1 mM ethylmercurithiosalicylate 
(EMTS). Excess of EMTS was removed during 
the equilibration in cryoprotectant solutions 
consisting of 0.1 M imidazole (pH 7.6), 0.2 M Ca 
acetate, 12% (w/v) PEG 8000, and 5% to 20% 
glycerol. Data of the native and EMTS-soaked 
crystals were collected and processed as for the 
SR3-SR4 crystals. 
SR4-SR5-SH3 crystals belong to the space group 
P212121. The asymmetric unit contains two plectin 
molecules (~64% solvent content) that are related 
by a non-crystallographic translation about 1/2 
along axis c (0.00 0.00 0.46), which was evident 
as a peak in the native Patterson map. Phases were 
obtained by single isomorphous replacement with 
anomalous scattering (SIRAS) using the native 
and mercurial datasets. Calculation of approximate 
substructure amplitudes, heavy atom substructure 
determination, and initial phase calculations were 
done with ShelxC/D/E (44) and the HKL2MAP 
graphical interface (45). Phase probability 
distributions from the top four Hg-sites found by 
Shelx, were further refined with SHARP (46), and 
allowed for the identification of one additional 
minor Hg-site. Phase improvement and extension 
with Solomon (47) and DM (48) allowed the 
calculation of an interpretable electron density 
map (Supplemental fig. 1). Two copies of the SR4 
from the SR3-SR4 structure were located by 
phased-molecular replacement using MOLREP 
(49); in addition, -helices corresponding to the 
SR5 were built and two copies of a mixed model 
(37) of the SH3 domain based on the crystal 
structure of the SH3 of -spectrin (PDB code 
2PQH) were docked into the SIRAS map. 
Refinement was done with phenix.refine against 
native data to 2.95 Å. At early stages, refinement 
included simulated annealing, while individual 
positional and grouped B-factor (two groups per 
residue) refinement combined with the refinement 
of five TLS groups in each plectin molecule was 
done at later stages. Non-crystallographic 
symmetry restraints and main-chain H-bond 
distance restraints were used during refinement. A 
map calculated using the anomalous differences of 
the native dataset and the SIRAS phases has the 
two strongest peaks near Q792 in each of the 
molecules in the asymmetric unit (Supplemental 
fig. 2A) and the anomalous signal at theses 
positions was higher than at any of the sulfur 
atoms of the protein. Based on the environment 
(near the carbonyls of D789 and Q792) these 
peaks were modeled as Ca2+ ions whose B-factors 
were refined anisotropically. The final model has 
good geometry (Table 1) and contains residues 
642-915 in both chains, with the exception of 
residues 871-873 in molecule A and 830-832 in 
molecule B, for which no clear electron density 
was observed. 
 
Analysis of structures- Identification of residue 
pairs that could form disulfide bonds was done 
with the program SSBOND (50). Analysis of 
protein motions by pair-wise comparison of 
conformers was done with the program DynDom 
(51). Molecular figures were prepared using 
PyMOL (52). 
 
Titration of thiol groups- Sulfhydryl groups were 
titrated under denaturing conditions with 5,5'-
dithio-nis(2-nitrobenzoic acid) as described (22). 
 
SAXS measurements and analysis- SAXS 
measurements were performed at the cSAXS 
beamline at the Swiss Light Source (Villigen, 
Switzerland). The energy of the X-ray beam was 
adjusted to 12 KeV (=1.0 Å) and the distance 
from the sample to the detector (PILATUS 2M, 
Dectris Ltd.) was 2.15 meters, covering a 
scattering vector range (q = 4πsinθ/λ) from 0.015 
to 0.5 Å-1, as determined by the silver behenate 
scattering profile. The buffers used for the last gel 
filtration step of the protein purifications, 
containing 5% (v/v) glycerol and 2.5 mM DTT, 
and protein samples were measured consecutively 
in the same borosilicate capillary (Ø 1 mm, 
Hilgenberg GmbH), using an in house designed 
thermostatized copper holder. Sample temperature 
was set to 10  1°C for all the measurements. Data 
frames were recorded every 0.5 seconds, for a total 
exposure time of 30 seconds, at 10 different 
positions (0.5 mm spacing) in the capillary, to 
reduce radiation damage. Data sets were collected 
from SR3-SR4-SR5-SH3 protein at concentrations 
of 1.2, 2.4, 4.8, and 9.6 mg/ml. Data reduction and 
analysis was performed using the ATSAS package 
(53), according to standard procedures. 
The theoretical scattering profiles of atomic 
models were calculated and fitted to the 
experimental data with the program CRYSOL 
(54). The pair-distance distribution, P(r), of 
5 
atomic models was calculated with the program 
HYDROPRO (55). 
 
Construction of an atomic model of the SR3-SR4-
SR5-SH3 region- The structure of the SR3-SR4 
region was superposed onto that of SR4-SR5-SH3 
by fitting the positions of the C atoms of the 
central region of the helical bundle of the SR4, 
residues 647-661, 686-706, and 721-742. Models 
were built by combining the regions 543-660 and 
692-727 of the moved SR3-SR4 structure with the 
regions 661-691, 728-915 of the structure of SR4-
SR5-SH3. 
 
Protein Data Bank accession numbers- The 
atomic coordinates and structure factors of the 
SR3-SR4 and SR4-SR5-SH3 structures have been 
deposited in the Research Collaboratory for 
Structural Bioinformatics Protein Data Bank under 
ID codes 3PDY and 3PE0. The coordinates of the 
atomic model of the SR3-SR4-SR5-SH3 are 
available from the authors. 
 
RESULTS 
In order to study the structure of the central 
region of the plakin domain, the following three 
fragments of human plectin were expressed as 
soluble proteins (Fig 1A). A first construct 
contains the third and fourth SR (SR3-SR4), 
residues 543-748; a second fragment corresponds 
to the fourth and fifth SR and the SH3 (SR4-SR5-
SH3), residues 640-918. A third construct, SR3-
SR4-SR5-SH3, contains the whole region covered 
by the previous fragments, residues 543-918. 
 
Structure of the SR3-SR4 region of plectin- The 
SR3-SR4 protein yielded crystals that diffracted to 
2.22 Å. The structure was refined to a final Rfree of 
24.8% (Table 1) (Fig 1B). The asymmetric unit 
contains two SR3-SR4 polypeptides that have a 
similar overall structure with minor differences 
(see below). Each repeat has the canonical SR 
fold, consisting of three -helices (A, B, and C). 
The structures of each individual SR in the two 
molecules present in the asymmetric unit of the 
crystal are almost identical; the rmsd for all 
equivalent main chain atoms is 1.19 Å and 0.54 Å 
for the SR3 and SR4, respectively. The only 
significant differences between the two structures 
are located at the first two turns of helix A and the 
B/C loop of the SR3, which pack slightly tighter in 
one of the molecules than in the other, due to 
different crystal contacts. 
The structure of the SR3-SR4 of plectin is 
very similar to that of the equivalent repeats of 
BPAG1 (PDB code 2IAK) (29), as expected from 
the 52% sequence identity between plectin and 
BPAG1 in this region. After superposition of each 
individual repeat of the BPAG1 structure onto the 
equivalent SR of plectin the rmsd for all main 
chain atoms is 1.00-1.32 Å for the SR3 (values 
from the comparison with each of the two copies 
of plectin in the asymmetric unit) and 0.75-0.79 Å 
for the SR4. Our structure of the SR3-SR4 of 
plectin was refined against significantly higher 
resolution data than that of BPAG1, 2.22 Å versus 
3.0 Å, and reveals details that were not visible in 
the BPAG1 structure. These include the A/B loop, 
the first two turns of helix B and the side chains of 
residues in the helices A and B of the SR4 
(Supplemental fig. 3A). The helix A is about two 
turns shorter than the adjacent helices B and C; 
thus, the A/B loop covers the hydrophobic core. 
In addition to the structural similarity of the 
individual repeats, the arrangement of the SR3-
SR4 tandem is also very similar in plectin and 
BPAG1, and it is different from that observed in 
other structures of tandem SRs. 
 Comparison of the two molecules of plectin 
present in the asymmetric unit reveals small 
differences in the relative orientation of the SR3 
and SR4. After superposition of the SR3 of both 
molecules there is a ~4.5 Å difference in the 
position of the C atoms of residues in the A/B 
loop of SR4. The two conformations are related by 
a closure motion with the hinge located at the 
SR3/SR4 boundary (Supplemental fig. 4). 
Superposition of the BPAG1 structure with those 
of plectin reveals variations in the interdomain 
orientation of similar amplitude as observed 
between the plectin molecules and further 
illustrates the moderate plasticity of the SR3-SR4 
tandem. 
 
Structure of the SR4-SR5-SH3 region of plectin- 
The crystal structure of the SR4-SR5-SH3 region 
of plectin was solved by SIRAS using a mercurial 
derivative and was refined against data to 2.95 Å 
resolution (Table 1) (Fig. 1C). The asymmetric 
unit contains two molecules of SR4-SR5-SH3 
which are almost identical (the rmsd for all 
equivalent main-chain atoms is 0.33 Å) as 
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expected from the required use of non-
crystallographic symmetry restraints throughout 
refinement. 
The structure of the SR4 in the SR4-SR5-
SH3 molecule is very similar to that observed in 
the SR3-SR4 polypeptide. The only noticeable 
difference in the SR4 between the two structures 
resides in the A/B loop (Supplemental fig. 3). In 
SR4-SR5-SH3 the A/B loop contacts the SH3 and 
the SR5 (see below). The sites for this contact are 
absent in the SR3-SR4 structure. Thus, the native 
conformation of the A/B loop in the full length 
protein is better represented by the SR4-SR5-SH3 
structure  
The SR5 exhibits the characteristic SR fold. 
In addition, it has a unique 10-residues long helix-
B0 upstream of helix B, which protrudes at the end 
of the longitudinal axis of the three-helix bundle. 
Helix B0 has a patch of hydrophobic residues 
(V784, L787, L790, and L791) that in our crystal 
structure binds in a coiled-coil fashion to the SR4 
of a neighboring molecule (Supplemental fig. 2B). 
It is reasonable that in the full length plectin the 
hydrophobic-rich surface of helix B0 might 
establish analogous interactions with the region 
downstream of SR5, which is predicted to consist 
of a SR-like domain (SR6) (30). The structure 
contains a Ca2+ ion near the C-terminus of helix 
B0. Calcium was present in high concentration in 
the crystallization solution (0.2 M calcium 
acetate). In addition, Ca2+ concentrations up to 0.1 
M had no effect on the thermal stability of the 
protein in solution (data not shown). Thus, the 
observed bound Ca2+ does not represent a 
functional Ca2+-binding site at physiological 
concentrations.  
The SR4-SR5 tandem forms an elongated 
structure. Helices A and B of SR4 and helices B 
and C of SR5 lie approximately on opposite sides 
of the A-C interdomain helix. Thus, there is no 
direct contact between the SR4 and the SR5 other 
than those that occur at the helical linker. In 
summary, the SH3 domain does not alter the 
overall canonical fold of the SR5 or the rod-like 
structure of the tandem array of SRs. 
The SH3 of plectin exhibits the 
characteristic overall fold observed in other SH3 
domains. It consists of five -strands (1 to 5) 
that adopt a -barrel structure (56). The N-
terminus of the SH3 domain is connected to helix 
B of SR5 by a 16-residue long segment, while the 
C-terminus of the SH3 is linked to helix C by a 
short sequence. We called these segments the 
upstream and downstream linkers, respectively. 
Despite being inserted within the sequence 
of the SR5, the SH3 domain does not contact the 
SR5, but it makes an extensive interaction with the 
SR4, which occludes ~560 Å2 of the solvent 
accessible area of the SH3 and a similar area of the 
SR4. The inter-domain contacts are mainly 
hydrophobic (Fig. 2). The SR4-binding surface in 
the SH3 domain is centered on V881 in the 4/5 
loop; its side chain docks into a hydrophobic 
pocket in the SR4 formed by residues V667, 
W671, W733, L737, C740, and H744, which are 
located in the A/B loop and the helix C. The N-
terminal part of the 1/2 loop (known as the RT-
loop), also contributes to the interaction. C740 in 
SR4 and C840 and C882 in the SH3 form a Cys-
cluster buried at the SR4-SH3 interface. Analysis 
of a native anomalous difference map calculated 
using the SIRAS-derived phases revealed three 
independent peaks that can be assigned to the 
sulfur atoms of these Cys. The distances between 
the anomalous difference peaks are larger than the 
expected S-S distance in a disulfide bridge 
(Supplemental fig. 5). Titration of the sulfhydryl 
groups of the SR4-SR5-SH3 protein in the absence 
of reducing agents yields 7.0 ± 0.1 free sulfhydryls 
per molecule, which reveals that all Cys are 
reduced. Thus, the thiol groups of C740, C840, 
and C882 where modeled reduced in our structure.  
The SR4-SH3 interaction is further 
stabilized by the upstream linker (residues 817-
833), which is inserted as a wedge between the 
SR4 and the SH3. L821 docks into a pocket on the 
SR4. R824 is buried in between the SR4 and SH3 
and probably makes H-bonds with both domains. 
The downstream linker (residues 886-889) makes 
minor contacts with the SH3 and the N-terminus 
of the upstream linker, but it does not contact the 
SR4 directly. This short linker consists mostly of a 
Pro cluster (886PPP888), suggesting that it provides 
a well defined anchorage of the SH3 C-terminus to 
the SR5. Thus, it is likely that the downstream 
linker favors the interaction of the SH3 with the 
SR4 by limiting the conformational freedom of the 
SH3 domain. 
 
The SR4/SH3 interface is conserved in plakins but 
not in -spectrins- The residues of the SR4, the 
SH3, and the linkers that form the intramolecular 
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interface are conserved in other plakins 
(Supplemental fig. 6), suggesting that the 
arrangement of the SR4 and SH3 observed in 
plectin is conserved throughout the plakin family. 
Similar to plakins, -spectrins contain an 
SH3 domain inserted in the B/C loop of its ninth 
SR (SRs numbering according to (57)). 
Nonetheless, -spectrins show significant 
differences with plakins at the residues involved in 
the SR4-SH3 interaction in plectin. The positions 
of the SR8 of -spectrin, equivalent to the residues 
that form the hydrophobic-rich interaction surface 
in the SR4 of plectin, are occupied by polar 
residues. In the SH3 domain, the positions of two 
Cys residues of plectin (C840 and C882) that face 
the SR4 are occupied by tyrosines in -spectrins. 
The sequences of the upstream and downstream 
linkers in -spectrins do not show similarities with 
those of plakins. In summary, all the structural 
elements of the SR4-SH3 interaction present in 
plakins are different in -spectrins. 
 
The putative binding site of the SH3 domain of 
plectin is distorted and occluded- SH3 domains 
are generally involved in protein-protein 
interactions. A majority of SH3 domains recognize 
ligands with Pro-rich sequences containing the 
core motif XPXXP that, when bound, adopts a 
poly-Pro type II helix conformation (34,56,58). 
The poly-Pro binding site in canonical SH3 
domains is located on the surface between the RT 
and n-Src loops. It has two parallel pockets, each 
of which recognizes a XP dipeptide on the ligand; 
hence, they are known as the XP-pockets. These 
pockets are formed by conserved aromatic 
residues in the RT-loop, the 4 strand, and the 
4/5 loop. Adjacent to one of the XP-pockets the 
RT and n-Src loops form the "specificity" or 
"compass" pocket that typically recognizes a basic 
residue that either precedes or follows the XPXXP 
motif. The putative binding site of the SH3 
domain of plectin shows significant differences 
with canonical poly-Pro binding sites (Fig 3A). 
First, three well-conserved aromatic residues that 
create the XP-pockets in canonical SH3 domains 
are substituted by amino acids with shorter side 
chains in plectin, namely, C840, H865, and C882. 
The presence of these three non-aromatic residues 
creates a rather flat surface in plectin instead of the 
two XP-pockets. Second, the RT-loop of plectin is 
three-residues shorter than that of typical SH3 
domains and the compass pocket of plectin is 
wider than that of other SH3 domains. 
The aforementioned differences in the 
putative binding site of plectin are present in the 
other members of the plakin family (Fig 3B). 
C840 and C882 are highly conserved in plakins. 
On the other hand, H865 and A877, which 
contribute to the compass pocket, are poorly 
conserved within the family; H865 is most 
frequently substituted by Lys, while there is higher 
variability at the position equivalent to A877. 
Finally, the pseudo poly-Pro binding site of 
plectin is partially occluded by the intramolecular 
interaction between the SR4 and the SH3 domains. 
C840, Y842, P879, and C882 contribute to the 
interface (see above) suggesting that in plectin and 
other plakins the area of the XP-pockets has 
evolved to engage in an intramolecular interaction 
instead of ligand recognition. On the other hand, 
the compass pocket is accessible on the surface. 
 
Structure of the SR3-SR4-SR5-SH3 region- 
Attempts to crystallize the SR3-SR4-SR5-SH3 
region of the plakin domain of plectin were 
unsuccessful. Nonetheless, we have built an 
atomic model of this region using as templates the 
crystal structures of the SR3-SR4 and SR4-SR5-
SH3 fragments, which share the SR4. 
In order to experimentally evaluate the 
composite atomic model we have analyzed the 
structure in solution of the SR3-SR4-SR5-SH3 
region, residues 543-918, by SAXS, which can 
provide accurate shape information. The 
experimental scattering profile is shown in figure 
4A. The apparent molecular weight of SR3-SR4-
SR5-SH3 calculated from the estimated excluded 
volume was 45.2 ± 0.5 kDa, which is in agreement 
with the molecular weight calculated from its 
sequence (43310 Da) and confirms that this 
fragment of plectin is a monomer in solution. 
Guinier analysis of the scattering data revealed 
that SR3-SR4-SR5-SH3 has a radius of gyration 
(RG) of 43.9 ± 4.5 Å (Supplemental fig. 7). This 
value lies within the experimental error with the 
RG of 42.9 ± 2.3 Å determined in the calculation of 
the pair-distribution probability function (P(r)) 
using data covering a range of the scattering vector 
from 0.017 to 0.35 Å-1. The P(r) has a maximum 
dimension (Dmax) of 145 Å (Fig. 4B). 
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The SAXS scattering curve and the distance 
distribution calculated for the atomic model were 
almost identical to the experimental scattering 
profile and the SAXS-derived P(r) (Fig. 4). The 
RG and the Dmax of the model are 40.3 Å and 155 
Å, respectively; yet 99.99% of the distances occur 
at D<147 Å, in very close agreement with the RG 
and the Dmax values determined from the SAXS 
measurements. Moreover, there is a good 
agreement between the atomic model and low 
resolution envelopes derived from the SAXS data 
(Supplemental fig. 8). In summary, the atomic 
model of the SR3-SR4-SR5-SH3 region provides a 
realistic representation of the structure of this 
region in solution. 
The model of the SR3-SR4-SR5-SH3 region 
reveals that helices A and B of the SR3 lie on the 
same side of the SR4 as the SH3 domain creating a 
C-shaped groove (Supplemental fig. 9). At the 
center of this groove, residues in helices A and C 
of the SR4 form a hydrophobic surface that is 
flanked by polar and acidic residues.  
 
DISCUSSION 
The plakin domain of plectin and other 
plakins harbors protein-protein interaction sites. 
The central region of the plakin domain of plectin 
characterized herein participates in the interaction 
with junctional proteins such as the integrin 4 
subunit and the cytoplasmic domain of BPAG2 in 
epithelia and with -dystroglycan and -synemin 
in skeletal muscle. The precise binding sites in the 
plakin domain are not known. The presence of an 
SH3 domain in this region is of interest because 
SH3 domains often mediate protein-protein 
interactions. SH3 domains frequently recognize 
Pro-rich ligands. In the putative binding site of the 
SH3 domain of plectin there are substantial 
structural differences with that of canonical 
domains. Substitutions of residues that form the 
PXXP-binding site of archetypical SH3 domains 
compromise their recognition of these ligands. 
Thus, the structure of the SH3 domain of plectin is 
not compatible with it binding to Pro-rich motifs. 
The residues that form the putative binding site of 
the SH3 of plectin are also present in other 
plakins, suggesting that none of them recognize 
Pro-rich sequences in a canonical manner. In fact, 
to date no Pro-rich ligand has been identified for 
the SH3 domain of plectin or other plakins. Thus, 
in plakins we refer to this area as a poly-Pro 
pseudo-binding site. On the other hand, this 
pseudo-binding site is involved in the interaction 
with the SR4, suggesting that it has evolved to 
stabilize this intramolecular contact. 
Some SH3 domains engage in protein-
protein interactions via alternative mechanisms 
including the binding to short non-Pro-rich 
sequence motifs or to globular domains via tertiary 
contacts; and some of these interactions involve 
regions of the SH3 domain other than the 
canonical PXXP-binding groove (34). Thus, it is 
still possible that the SH3 domain of plectin might 
mediate or contribute to the association with 
junctional proteins via a non-PXXP-binding 
mechanism. 
In addition to the SH3 domain, the SRs of 
the plakin domain of plectin may also contain 
protein-protein binding sites, similar to those 
found in - and -spectrins (59). It is possible that 
in plectin the binding-sites for some ligands 
include both the SH3 domain and one or more 
SRs. The domain arrangement of the SR3-SR4-
SR5-SH3 region, as observed in the crystal 
structures and the SAXS-validated atomic model, 
defines multi-domain surfaces that may be 
relevant for ligand binding. For example, the 
groove created by the SR3, SR4 and SH3 domains 
might be a potential protein interaction site. 
The SR3-SR4-SR5 region forms a rod-like 
structure ~145 Å in length. Most likely the rod-
like structure continues throughout the additional 
repeats, SR6 to SR9, to reach an estimated total 
extension over 400 Å. Thus, in addition to harbor 
protein-protein interaction sites the plakin domain 
sustains two structural roles. First, it acts as a 
structural spacer that in combination with the 
central rod domain separates the binding sites in 
the N- and C-terminus of plectin. Thus, it 
facilitates the crosslinking role of plakins. Second, 
the SR3-SR4-SR5 array, and by extension the rest 
of the plakin domain, resembles a semi-flexible 
rod. Analysis of the SR3-SR4 structures reveals a 
putative hinge movement of small amplitude 
centered at the SR3/SR4 linker. Similar bending 
movements have been described in multi-repeat 
fragments of - and -spectrin (60-61) and they 
are likely to occur at other inter-repeat linkers of 
the plakin domain. The SH3 domain, which is 
connected to the SR5 by a short and Pro-rich 
downstream linker and to the SR4 via a relatively 
large interface, is likely to reduce the bending at 
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the SR4/SR5 junction, suggesting that there are 
preferential points of flexibility. Finally, the plakin 
domain is likely to straighten or stretch under 
tensile forces; thus, binding to junctional proteins 
might be altered by force-driven conformational 
changes. Vice versa, association to other proteins 
could modify the mechanical properties of the 
plakin domain. In summary, the plakin domain 
might contribute to the stability of the 
cytoskeleton by allowing reversible deformation 
and the storage of energy during events of 
mechanical stress.  
An interesting feature of the SR4/SH3 
interface is the presence of a Cys-cluster formed 
by C740, C840, and C882 at the center of the 
contact surfaces, and the nearby C739 located at 
the edge of the interaction area. The pair 
C739/C840 is at an optimal distance for the 
formation of a disulfide bond, alternatively C840 
might form a disulfide bond with C740. In both 
cases the disulfide bond would link the SR4 to the 
SH3. The reducing environment of the cytosol 
would maintain the thiols free, as observed in the 
crystal structure; but in states of oxidative stress 
the reactive oxygen species might induce the 
formation of at least one disulfide bond between 
the SR4 and the SH3, which could have two 
effects. First, it might affect the affinity of plectin 
for some ligands due to a reduction in the 
conformational adaptability of this region. 
Similarly, oxidation of a Cys near the intermediate 
filament-binding site located in the C-terminal 
region of plectin reduces its affinity for vimentin 
(62). Second, disulfide crosslinking might reduce 
the flexibility of this segment of the plakin 
domain, increasing the stability of the plakin 
domain. Finally, C740 and C840 are highly 
conserved in the plakin family (Supplemental fig. 
6), suggesting that other plakins might also be 
subject to reversible redox regulation. The role of 
plakins during oxidative stress is not known; it is 
possible that they contribute to the proposed 
cytoprotective role against stress of intermediate 
filament proteins (63). 
Overall, the structures of the plakin domain 
presented here extend the similarities between 
plakins and other members of the spectrin 
superfamily. Nonetheless, there are significant 
differences in the organization of the SH3 domain 
and the SR-array between plakins and -spectrins. 
Thus, plakins constitute a distinct group within the 
spectrin superfamily. The pseudo-binding site of 
the SH3 domain and the SR4/SH3 interface are 
widely conserved among plakins including those 
of nematodes and insects, which contain a single 
plakin gene. Thus, the plakin-specific role of the 
SH3 was acquired early after the spectrin-plakin 
branching and the SR4/SH3 association has been 
maintained ever since, suggesting that it may be 
required for the architecture and function of all 
plakins. 
 The SR4-SR5-SH3 of plectin has striking 
similarities with the recently determined structure 
of the SR13-SR14-SR15 of I-spectrin in complex 
with the ZU5-ANK domain of ankyrin (64). The 
orientation of the ZU5-ANK, the SR14 and the 
SR15 in the complex resembles the arrangement 
of the SH3, SR4 and SR5 domains of plectin, 
respectively. After superposition of the SR14 of 
I-spectrin on the SR4 of plectin, the ZU5-ANK 
and the SH3 domains, in spite of having unrelated 
tertiary structures, occupy an equivalent position 
(Fig. 5). Moreover, the B/C loop of the SR15 of 
I-spectrin coincides with the insertion points of 
the SH3 domain in the same loop of the SR5 of 
plectin. Finally, R948 of ankyrin occupies the 
equivalent position to V841 of the SH3 of plectin, 
and its guanidinium group docks in a polar pocket 
in the SR14 located in the equivalent position of 
the hydrophobic cavity in the SR4 of plectin that 
accommodates the side chain of V841. The 
similarities between the ankyrin-binding site in the 
SR14-SR15 fragment of I-spectrin and the SH3-
interaction site in the SR4-SR5 of plectin suggests 
that they might reveal a protein-protein interaction 
area (inter- or intra-molecular) which is also 
present in arrays of other SRs, which involves the 
A/B loop and the helix C of an SR and the B/C 
loop of the following SR. Nonetheless, further 
structural characterization of SR interactions will 
be necessary to understand whether the plectin and 
I-spectrin/ankyrin structures illustrate a 
preferential binding mode or that they share a 
serendipitous resemblance. 
In summary, in this study we have 
progressed from the elucidation of structures of di-
repeat fragments of the plakin domain to that of a 
multi-repeat region. The emerging rod-like 
structure suggests that in addition to the 
scaffolding role, the plakin domain also 
contributes to the mechanical stability of the 
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cytoskeleton and its anchorage to junctional 
complexes. Our work paves the way to the 
elucidation of the complete structure of the plakin 
domain and to asses its role in maintaining the 
integrity of healthy tissues and in disease linked to 
defects of plakins. 
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FIGURE LEGENDS 
 
Fig. 1. Crystal structure of the SR3-SR4 and SR4-SR5-SH3 regions of the plakin domain of plectin. (A) 
Schematic representation of the domain structure of plectin and a close up view on the structure of the 
plakin domain. The three proteins characterized in this study are aligned underneath. (B, C) Two 
orthogonal views of ribbon representations of the crystal structures of the SR3-SR4 (B) and the SR4-SR5-
SH3 (C) regions. The SR4 is shown in equivalent orientations in both panels. 
 
Fig. 2. The intramolecular interface between the SR4 and the SH3 domain of plectin. (A) Footprint of the 
SH3 domain and the upstream linker on the surface of the SR4. Residues in SR4 that participate in the 
intramolecular contact are labeled on the surface and are colored according to the percentage of the 
accessible surface buried as defined by the protein interfaces, surfaces and assemblies service (PISA) 
(65): dark blue for residues mostly occluded (≥70% buried area) and light blue for residues partially 
occluded (≥20% and <70% buried area). The backbone of the upstream linker (purple) and the SH3 
domain (orange) is partially shown as a wire, and the side chains of the main residues that contact the SR4 
are shown as sticks and are labeled with arrows. The positions of the three -helices of the SR4 are 
labeled on top of the surface and the amino-to-carboxy direction indicated with arrow-heads. (B, C) 
Stereo representations of the intramolecular contacts between the SR4 (blue), the SH3 (orange), and the 
upstream linker (purple). The two lateral views in panels B and C are related by a 180º rotation around a 
vertical axis.  
 
Fig. 3. Structure of the putative binding site of the SH3 domain. (A) Ribbon representation of the SH3 
domain of plectin. The side chains of residues in positions equivalent to those that form the binding 
pockets in canonical SH3 domains are shown as sticks. The side chain of E846 was not modeled beyond 
its C atom due to lack of well-defined electron density; an arbitrary conformation is shown here. (B) 
Multiple sequence alignment of the SH3 domain of human plectin (Uniprot Q15149-2) with those of 
other human plakins: BPAG1e (Q03001-3), MACF1 (Q9UPN3-2), desmoplakin (P15924), envoplakin 
(Q92817), and periplakin (O60437); plakins from invertebrates: VAB-10A from Caenorhabditis elegans 
(Q86NF8) and Shot from Drosophila melanogaster (A1Z9J1); and two human -spectrins: I-spectrin 
(erythrocyte, P02549), and II-spectrin (brain, Q13813). The secondary elements of the plectin structure 
are shown above the alignment. Conserved residues that form the binding pockets in -spectrin are shown 
with blue boxes, while residues of plakins unlikely to sustain binding in a canonical manner are shown 
with light-red boxes. 
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Fig. 4. SAXS analysis of the SR3-SR4-SR5-SH3 region. (A) Scattering profile of SR3-SR4-SR5-SH3 
(open circles). The theoretical scattering curve of the atomic model (dashed line) shows a good fit to the 
experimental data. (B) Pair-distance distribution curves estimated from the SAXS data using the program 
GNOM (solid line) and calculated for a hydrated model of the atomic structure (dashed line).  
 
Fig. 5. Similar domain arrangement in the SR4-SR5-SH3 of plectin and the complex formed by I-
spectrin and ankyrin R. (A) Worm representation of the structure of the SR4-SR5-SH3 of plectin, the 
orientation is the same as in fig 1C. (B) Structure of the ZU5-ANK domain of ankyrin R bound to the 
SR14-SR15 of I-spectrin (PDB code 3KBT); the SR13, which is present in the crystal structure of the 
complex but does not contact the ZU5-ANK domain, has been omitted. (C) Orthogonal views of the 
ankyrin/I-spectrin and the plectin structures after superposition of the SR14 of I-spectrin onto the SR4 
of plectin. (D) Close up view of the SH3/SR4 and ZU5-ANK/SR14 interfaces in plectin and the 
ankyrin/I-spectrin complex, respectively. The side chain of V881 in the SH3 of plectin and R948 in the 
ZU5-ANK domain occupy equivalent positions and are shown as sticks. For clarity, only a segment of the 
backbones around V881 and R948 are shown. 
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Table 1. Summary of crystallographic analysis 
Data Collection     
Protein SR3-SR4 (543-748)  SR4-SR5-SH3 (640-918) 
Data set Native  Native 1 mM EMTS 
Space group P21212  P212121 P212121 
Cell dimensions a = 97.4 Å 
b = 119.4 Å 
c = 44.6 Å 
 a = 72.7 Å 
b = 108.5 Å 
c = 112.1 Å 
a = 72.2 Å 
b = 107.9 Å 
c = 113.0 Å 
Wavelength (Å) 1.5418  1.5418 1.5418 
Resolution (Å) 2.22 (2.30-2.22)a  2.95 (3.05-2.95)a 3.40 (3.53-3.40)a 
Unique reflections 26066  18051 22352 b 
Redundancy 7.0 (5.9)a  14.3 (14.5)a 7.8 (7.7)a 
Completeness (%) 98.4 (92.1)a  93.6 (85.5)a 95.1 (98.6)a 
Rmeasc (%) 6.0 (44.4)a  5.9 (43.9)a 8.9 (62.4)a 
Mean I/I) 23.1 (4.9)a  29.4 (6.9)a 16.5 (3.9)a 
Risof (%)    32.1 
Phasing power (iso acent / iso cent / ano)    0.84 / 0.92 / 0.64 
FOM SHARP (acentric / centric)    0.16 / 0.17 
Refinement statistics     
Resolution range (Å) 20 - 2.22  20 - 2.95  
Unique reflections, work/free 24757 / 1315  17102 / 925  
R work (%) 20.4  24.1  
R freee (%) 24.8  26.5  
Number of  
residues 
waters 
Ca2+ 
Other hetero-compounds 
 
407 
210 
0 
2 
  
542 
0 
2 
0 
 
Average B value (Å2) 
Wilson plot 
Protein 
Solvent 
Ca2+ 
Other hetero-compounds 
 
34.0 
40.1 / 41.7 
44.1 
- 
52.9 
  
75.3 
91.2 / 88.3 
- 
84.2 
- 
 
rmsd bond lengths (Å) 0.004  0.013  
rmsd angles (º) 0.679  1.031  
Ramachandran plot f, residues in 
Favored regions 
Additionally allowed 
Outliers 
 
401 (99.5%) 
2 (0.5%) 
0 (0.0%) 
  
517 (96.8%) 
17 (3.2%) 
0 (0.0%) 
 
PDB accession code 3PDY  3PE0  
a Numbers in parenthesis correspond to the outer resolution shell. 
b Keeping Bijvoet pairs separate. 
c Rmeas is the multiplicity independent R factor as described by Diederichs and Karplus (66). 
d Riso = ∑||Fder|-|Fnat||/∑|Fnat|, where Fder is the heavy-atom derivative structure factor and Fnat is the 
protein structure factor. 
e Calculated using 5% of reflections that were not included in the refinement. 
f As defined in the program MOLPROBITY (67). 
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Supplemental figure 1. SIRAS map of the SR4-SR5-SH3 structure. (A, B) Stereo view of two representative 
areas of the map calculated using the SIRAS-derived phases, after density modification. The map is contoured at 1σ 
and the refined model is superposed. (A) Section corresponding to helices B and C of the SR4. (B) Section of the SH3 
domain around V881.
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2+Supplemental figure 2. Structure of the helix B0 of the SR5. (A) Structure of the Ca  site at the C-terminus of the 
2+helix B0. The Ca  corresponds to the highest peak in the native anomalous difference map calculated using the 
experimentally derived SIRAS phases, which is shown at two contour levels: 3.5 σ (light orange) and 7.0 σ (red). (B) 
Details of the interaction between helix B0 (green) and the SR4 (light blue) of a neighboring molecule in the crystal. 
The side chains of the residues at the interface are shown.
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Supplemental figure  3. Structure of the A/B loop of the SR4. (A) Stereo close up view of the region of the SR4 
around the A/B loop as observed in the structure of SR3-SR4. W671 is mostly buried at the core of the helical 
bundle. The side chains of D670 and N675 stabilize the conformation of the loop by making H-bonds. (B) Similar 
region in the SR4-SR5-SH3 structure. (C) Comparison of the backbone of the SR4 in the structures of the SR3-SR4 
and SR4-SR5-SH3. There is a difference of up to ~6 Å in the position of Cα atoms at the A/B loop between the SR3-
SR4 and the SR4-SR5-SH3 structures. For clarity, the SH3 domain is not shown in panels B and C.
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Supplemental figure 4. Identification of a hinge movement in the SR3-SR4 tandem by comparison of the 
structures of the two molecules in the asymmetric unit. Orthogonal views of the Cα-traces of the two SR3-SR4 
molecules after superposition of the SR4 domains. The structures are colored according to the moving domains 
identified with the program DynDom and correspond approximately to the SR3 (blue) and SR4 (green). Residues 
that act as a hinge (magenta) are located near the SR3/SR4 junction. The rotation axis of the predicted hinge 
movement is shown as a black line; the arrows indicate the direction of the movement.
Supplemental figure 5. Structure of the Cys cluster at the interface between the SR4 and the SH3 domain. 
Stereo representation of the region around the Cys cluster formed by C740, C840, and C882. The SR4 domain is 
colored in light blue and the SH3 domain in orange. A native anomalous difference map calculated using the SIRAS 
phases is shown contoured at 3.5 σ (red). The peaks of the anomalous difference map corresponding to the γ-sulfur 
atoms of C740, C840, and C882 are connected by dashed lines and their distances are indicated. An averaged kick 
2mF -DF  map calculated at the final stages of refinement and contoured at 1 σ is shown in grey.obs calc
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hPlectin         544 LEDSTLRYLQDLLAWVEENQHRVDGA---EWGVDLPSVEAQLGSHRGLHQSIEEFRAKIERARSDEGQLS---PATRGAYRDCLGRLDLQYAKLLN---SSKARLRS
hBPAG1e          274 EEEINMKFVQDLLNWVDEMQVQLDRT---EWGSDLPSVESHLENHKNVHRAIEEFESSLKEAKISEIQMT---APLKLTYAEKLHRLESQYAKLLN---TSRNQERHLDT 374
hMACF1           581 EDEGNLRFVYELLSWVEEMQMKLERA---EWGNDLPSVELQLETQQHIHTSVEELGSSVKEARLYEGKMS---QNFHTSYAETLGKLETQYCKLKE---TSSFRMRHLQS 681
hDesmoplakin     180 WDEFTKHVTSECLGWMRQQRAEMDMV---AWGVDLASVEQHINSHRGIHNSIGDYRWQLDKIKADLREKS------------AIYQLEEEYENLLK---ASFERMDHLRQ 271
hEnvoplakin      138 EKMVLPPDVGPRVDWARVLEQKQKQVCAGQYGPGMAELEQQIAEHNILQKEIDAYGQQLRSLVG-PDAAT----------------IRSQYRDLLK---AASWRGQSLGS 227
hPeriplakin      124 IYRLAVKEVDPQVNWAALVEEKLDKLNNQSFGTDLPLVDHQVEEHNIFHNEVKAIGPHLAKDGDKEQNSE----------------LRAKYQKLLA---ASQARQQHLSS 214
VAB-10A          532 MRKTSFSRVEECIEWVRVRMEKLTTM---EFLEDLETLEHVFEQHKFDNRDIQDFRQNVDECIARQAEVS---AEDTYEYCELLRVLESEYQQLRD---LSAGRMLDLDS 632
Shot             630 DTNPHFRDLQEHIEWCQNKLKQLLAA---DYGSDLPSVKEELDRQQHEHKIIDQFHTKILNDERQQTKFS---GDELALYQQRLNQLQKVYAELLS---TSTKRLSDLDS 730
SPTA1_HU         688 QQLQFENNAEDLQRWLEDVEWQVTSE---DYGKGLAEVQNRLRKHGLLESAVAARQDQVDILTDLAAYFEEIGHPDSKDIRARQESLVCRFEALKEPLATRKKKLLDLLH 794
SPTA2_HU         679 QQQQFNRNVEDIELWLYEVEGHLASD---DYGKDLTNVQNLQKKHALLEADVAAHQDRIDGITIQARQFQDAGHFDAENIKKKQEALVARYEALKEPMVARKQKLADSLR 785
hPlectin         645 LHSFVAAATKELMWLNEKEEEEVGFDWSDRNTNMTA-KKESYSALMRELELKEKKIKELQNAGDRLLREDHPARPTVESFQAALQTQWSWMLQLCCCIEAHLKENA 749
hBPAG1e          375 LHNFVSRATNELIWLNEKEEEEVAYDWSERNTNIAR-KKDYHAELMRELDQKEENIKSVQEIAEQLLLENHPARLTIEAYRAAMQTQWSWILQLCQCVEQHIKENT 479
hMACF1           682 LHKFVSRATAELIWLNEKEEEELAYDWSDNNSNISA-KRNYFSELTMELEEKQDVFRSLQDTAELLSLENHPAKQTVEAYSAAVQSQLQWMKQLCLCVEQHVKENT 786
hDesmoplakin     272 LQNIIQATSREIMWINDCEEEELLYDWSDKNTNIAQ-KQEAFSIRMSQLEVKEKELNKLKQESDQLVLNQHPASDKIEAYMDTLQTQWSWILQITKCIDVHLKENA 376
hEnvoplakin      228 LYTHLQGCTRQLSALAEQQRRILQQDWSDLMADPAGVRREYEHFKQHELLSQEQSVNQLEDDGERMVELRHPAVGPIQAHQEALKMEWQNFLNLCICQETQLQHVE 333
hPeriplakin      215 LQDYMQRCTNELYWLDQQAKGRMQYDWSDRNLDYPSRRRQYENFINRNLEAKEERINKLHSEGDQLLAAEHPGRNSIEAHMEAVHADWKEYLNLLICEESHLKYME 320
VAB-10A          633 LIAFVRAAQLELIWVSERESIEVTRNWSDIKQLDLPMLTNYYKQLLHEMELREKQYNDVHNQGAALLNQGHPAIRVIEVYLRQMQSQWDWLLALSKCLEEHLRDAL 738
Shot             731 LQHFLGQASAELQWLNEKEQVEITRDWAD-KQLDLPSVHRYYENLMSELEKREMHFATILDRGEALLNQQHPASKCIEAHLTALQQQWAWLLQLTLCLEVHLKHAT 835
SPTA1_HU         795 LQLICRDTEDEEAWIQETEP-SATSTYLGKDLIASKKLLNRHRVILENIASHEPRIQEITERGNKMVEEGHFAAEDVASRVKSLNQNMESLRARAARRQNDLEANV 899
SPTA2_HU         786 LQQLFRDVEDEETWIREKEP-IAASTNRGKDLIGVQNLLKKHQALQAEIAGHEPRIKAVTQKGNAMVEEGHFAAEDVKAKLHELNQKWEALKAKASQRRQDLEDSL 890
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Supplemental figure 6. Multiple sequence alignment. The sequence of the SR3-SR4-SR5-SH3 region of human plectin (Uniprot entry Q15149-2) was aligned 
with the equivalent region of the human sequences of BPAG1e (Q03001-3), MACF1 (Q9UPN3-2), desmoplakin (P15924), envoplakin (Q92817), periplakin 
(O60437), VAB-10A of Caenorhabditis elegans (Q86NF8), Shot of  Drosophila melanogaster (A1Z9J1), and with the region SR7-SR8-SR9-SH3 of αI-
spectrin (erythrocyte, P02549) and αII-spectrin (brain, Q13813). The secondary structure elements of the plectin structure are indicated above the sequence. The 
residues that participate in the contacts between the SR4, the upstream linker, and the SH3 are indicated by inverted triangles; solid and open symbols correspond 
to residues at the core and the periphery of the interface, respectively. Residues identical to those of plectin at the SR4/SH3 contact surface are indicated by green 
boxes, while substitutions likely to sustain similar contacts as those observed in plectin are shown in yellow boxes.
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hPlectin         750 AYFQFFSDVREAEGQLQKLQEALRRKNSCDRSATVTRLEDLLQDAQDEKEQLNEYKGHLSGLAKRAKAVVQLKPRHPAHPMRGR 833
hBPAG1e          480 AYFEFFNDAKEATDYLRNLKDAIQRKYSCDRSSSIHKLEDLVQESMEEKEELLQYKSTIANLMGKAKTIIQLKPRNSDCPLKTS 563
hMACF1           787 AYFQFFSDARELESFLRNLQDSIKRKYSCDHNTSLSRLEDLLQDSMDEKEQLIQSKSSVASLVGRSKTIVQLKPRSPDHVLKNT 870
hDesmoplakin     377 AYFQFFEEAQSTEAYLKGLQDSIRKKYPCDKNMPLQHLLEQIKELEKEREKILEYKRQVQNLVNKSKKIVQLKPRNPDYRSNKP 460
hEnvoplakin      334 DYRRFQEEADSVSQTLAKLNSNLDAKYSPAPGGPPGAPTELLQQLEAEEKRLAVTERATGDLQRRSRDVAPLPQRRN--PPQQP 415
hPeriplakin      321 DYHQFHEDVKDAQELLRKVDSDLNQKYGPDFKDR-YQIELLLRELDDQEKVLDKYEDVVQGLQKRGQQVVPLKYRRE--TPLKP 401
VAB-10A          739 NLKSFMEEASDAEAWIQEQSVRLENNYNRT-DFSLEEGERFLRELDEIKEILNKYHQVLMALTERCASISPLWQRGE--RIPHP 819
Shot             836 EYHQFFGEIKDAEQWLAKRDEILNSKFSQS-DFGLDQGETLLRGMQDLREELNAFGETVATLQRRAQTVVPLNKRRQ--PVNRQ 916
SPTA1_HU         900 QFQQYLADLHEAETWIREKEPIVDN---TNYGADEEAAGALLKKHEAFLLDLNSFGDSMKALRNQAN-ACQQQQAAPVEGVAGE 979
SPTA2_HU         891 QAQQYFADANEAESWMREKEPIVGS---TDYGKDEDSAEALLKKHEALMSDLSAYGSSIQALREQAQ-SCR-QQVAPTDDETGK 969
hPlectin         834 LPLLAVCDYKQV---EVTVHKGDECQLVGPAQPSHWKVLSSSGSEAAVPSVCFLVPPPN------QEVQEAVTRLEAQHQALVTLWHQLH 914
hBPAG1e          564 IPIKAICDYRQI---EITIYKDDECVLANNSHRAKWKVISPTGNEAMVPSVCFTVPPPN------KEAVDLANRIEQQYQNVLTLWHESH 644
hMACF1           871 ISVKAVCDYRQI---EITICKNDECVLEDNSQRTKWKVISPTGNEAMVPSVCFLIPPPN------KDAIEMASRVEQSYQKVMALWHQLH 951
hDesmoplakin     461 IILRALCDYKQD---QKIVHKGDECILKDNNERSKWYVTGPGGVDMLVPSVGLIIPPPN------PLAVDLSCKIEQYYEAILALWNQLY 541
hEnvoplakin      416 LHVDSICDWDSG---EVQLLQGERYKLVDNTEPHAWVVQGPGGETKRAPAACFCIPAPD------PDAVARASRLASELQALKQKLATVQ 496
hPeriplakin      402 IPVEALCDFEGE---QGLISRGYSYTLQKNNG-ESWELMDSAGNKLIAPAVCFVIPPTD------PEALALADSLGSQYRSVRQKAAGSK 481
VAB-10A          820 IKVTALCDYSDE---NVTIKAGDDVYLLDNSDLIKWTIRDISGAEGQVPSVVFRIPPTD------ARLTALLNRLLQQFEKLKKLWDKKH 900
Shot             917 GPVQAICAYKQQG--QLQIEKGETVTLLDNSGRVKWRVRTAKGQEGPIPGACLLLPPPD------QEAIDAAERLKRLFDRSVALWQKKH 998
SPTA1_HU         980 QRVMALYDFQARSPREVTMKKGDVLTLLSSINKDWWKVEAAD-HQGIVPAVYVRRLAHDEFPMLPQRRREEPGNITQRQEQIENQYRSLL 1068
SPTA2_HU         970 ELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVND-RQGFVPAAYVKKLDPAQSASR-ENLLEEQGSIALRQEQIDNQTRITK 1057
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Supplemental figure 6. (continuation)
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Supplemental figure 7. Guinier plot analysis of the SAXS data of the SR3-SR4-SR5-SH3. The experimental 
data in the range of 0.68 < qRg < 1.26 are shown as dots with error bars. The linear regression corresponds to an Rg 
value of 43.9 ± 4.5 Å.
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Supplemental figure 8. Low resolution structure of SR3-SR4-SR5-SH3 in solution. (A) Three orthogonal 
views of an envelope calculated ab initio from the SAXS data with DAMMIF (1). (B) Equivalent envelope 
calculated with the program DALAI_GA (2). Ten independent models were generated with each program. The 
average values of the normalized spatial discrepancy (NSD), a parameter that represents quantitatively the 
similarity between three-dimensional models (3), of the ten-model sets calculated with DAMMIF and DALAI_GA 
were 0.59 ± 0.03 and 0.63 ± 0.02, respectively. Thus, both programs yield stable reconstructions. Each series of ten 
structures was used to calculate an averaged model the DAMAVER suite (4), which represents the most populated 
volume within each set of models. The averaged models obtained with both programs were very similar and were 
consistent within the SAXS resolution; the NSD value between them was 0.56. The DAMMIF-generated structure 
consists of a rod, ~30 Å in diameter and ~145 Å in length, with a bulge on one side. The bulge is off-centered along 
the longitudinal axis of the structure and defines a long and a short arm in the rod. The DALAI_GA model appears 
to be a bend rod; the overall dimensions are as in the DAMMIF model and the bent coincides with the bulge. The 
atomic model of SR3-SR4-SR5-SH3 is shown in both panels onto the low resolution envelopes after 
superimposition using the program SUPCOMB (3), which reveals good agreement between the high and low 
resolution structures.
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Supplemental figure 9. The SR3, SR4 and SH3 define an inter-domain concave surface. (A) Structure around 
the area of the SR4 flanked by the A/B loop of the SR3 and the SH3 domain. This region contains a hydrophobic 
patch in SR4 (L656, M657, F723, A725, and A726) in between acidic and polar residues of the SR3 (D574), SR4 
(N660, E663, E664, E721, and Q730) and SH3 domain (Q844 and Q862). For clarity, only the side chains of the 
residues involved in this surface are shown. (B) Molecular surface of this region in the same orientation as in (A) 
(left) and rotated 90º (right). The surface is colored according to the electrostatic potential at the surface at -18 
K T/e  (red) and +18 K T/e  (blue), calculated with the program APBS (5).b c b c
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